PNC FINANCIAL SERVICES GROUP, INC. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,533
-67.5%
308
-28.2%
0.00%
Q2 2023$10,859
-48.1%
429
-34.0%
0.00%
Q1 2023$20,936
+74.5%
6500.0%0.00%
Q4 2022$12,000
-7.7%
650
+37.7%
0.00%
Q3 2022$13,000
+116.7%
4720.0%0.00%
Q2 2022$6,000
-40.0%
4720.0%0.00%
Q1 2022$10,000
-85.3%
472
-88.4%
0.00%
Q4 2021$68,000
+385.7%
4,068
+738.8%
0.00%
Q3 2021$14,0000.0%4850.0%0.00%
Q2 2021$14,0000.0%4850.0%0.00%
Q1 2021$14,000
+180.0%
485
+193.9%
0.00%
Q4 2020$5,0000.0%1650.0%0.00%
Q3 2020$5,0000.0%1650.0%0.00%
Q2 2020$5,000
+400.0%
165
+25.0%
0.00%
Q1 2020$1,0000.0%1320.0%0.00%
Q4 2019$1,000132
+175.0%
0.00%
Q3 2019$0480.0%0.00%
Q2 2019$0480.0%0.00%
Q1 2019$0480.0%0.00%
Q4 2018$0
-100.0%
480.0%0.00%
Q3 2018$2,0000.0%480.0%0.00%
Q2 2018$2,0000.0%480.0%0.00%
Q1 2018$2,0000.0%480.0%0.00%
Q4 2017$2,000480.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$48,000,00065.50%
Essex Woodlands Management, Inc. 3,842,047$118,335,00025.90%
Rhenman & Partners Asset Management AB 203,181$6,258,0000.77%
EAM Global Investors LLC 44,898$1,383,0000.72%
Fosun International Ltd 319,313$9,835,0000.62%
EAM Investors, LLC 113,096$3,483,0000.58%
ArrowMark Colorado Holdings LLC 1,735,699$53,460,0000.53%
Perceptive Advisors 618,957$19,064,0000.53%
ESSEX INVESTMENT MANAGEMENT CO LLC 111,360$3,430,0000.45%
Schonfeld Strategic Advisors LLC 83,700$2,578,0000.19%
View complete list of REVANCE THERAPEUTICS INC shareholders